[1]
|
Miller, P.D. (2016) Management of Severe Osteoporosis. Expert Opinion on Pharmacotherapy, 17, 473-488.
https://doi.org/10.1517/14656566.2016.1124856
|
[2]
|
中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017) [J]. 中华骨质疏松和骨矿盐杂志, 2017, 10(5): 413.
|
[3]
|
Biver, E. and Ferrari, S. (2020) Osteoporosis. Revue Medicale Suisse, 16, 78-80.
https://doi.org/10.53738/REVMED.2020.16.676-77.0078
|
[4]
|
Reid, I.R. (2020) A Broader Strategy for Osteoporosis Interventions. Nature Reviews Endocrinology, 16, 333-339.
https://doi.org/10.1038/s41574-020-0339-7
|
[5]
|
Wang, T., Liu, Q., Tjhioe, W., et al. (2017) Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis. Current Drug Targets, 18, 1051-1068. https://doi.org/10.2174/1389450118666170321105425
|
[6]
|
Xiao, Y.P., Zeng, J., Jiao, L.N., et al. (2018) Review for Treatment Effect and Signaling Pathway Regulation of Kidney-Tonifying Traditional Chinese Medicine on Osteoporosis. China Journal of Chinese Materia Medica, 43, 21-30.
|
[7]
|
Suvarna, V., Sarkar, M., Chaubey, P., et al. (2018) Bone Health and Natural Products—An Insight. Frontiers in Pharmacology, 9, 981. https://doi.org/10.3389/fphar.2018.00981
|
[8]
|
He, J.B., Chen, M.H. and Lin, D.K. (2017) New Insights into the Tonifying Kidney-Yin Herbs and Formulas for the Treatment of Osteoporosis. Archives of Osteoporosis, 12, 14. https://doi.org/10.1007/s11657-016-0301-4
|
[9]
|
邓昶, 周明旺, 付志斌, 等. 骨质疏松症的中医病因病机及其治疗进展[J]. 中国骨质疏松杂志, 2017, 23(8): 1105-1111.
|
[10]
|
Li, Y., Tong, J., Zhou, Y.J., et al. (2015) Research Progress on Anti-Osteoporotic Active Ingredients and Pharmacological Action Mechanism of Traditional Chinese Kidney-Tonifying and Bone-Strengthening Drugs. China Journal of Chinese Materia Medica, 40, 1038-1043.
|
[11]
|
梁伟乔, 钟诚, 李宇明. 骨质疏松症的中医病因病机认识与治疗进展[J]. 中国骨质疏松杂志, 2020, 26(1): 135-139.
|
[12]
|
王晶, 许金海. 骨质疏松症与中医体质类型关系的Meta分析[J]. 中医正骨, 2022, 34(6): 29-33+52.
|
[13]
|
Zhang, X., Robles, H., Magee, K.L., et al. (2021) A Bone-Specific Adipogenesis Pathway in Fat-Free Mice Defines Key Origins and Adaptations of Bone Marrow Adipocytes with Age and Disease. eLife, 10, e66275.
https://doi.org/10.7554/eLife.66275
|
[14]
|
权祯, 秦大平, 张晓刚, 等. 基于中医“治未病”理念探讨其对骨质疏松症可控性危险因素的防治策略[J]. 中国骨质疏松杂志, 2021, 27(5): 747-752+758.
|
[15]
|
Mukwaya, E., Xu, F., Wong, M.S., et al. (2014) Chinese Herbal Medicine for Bone Health. Pharmaceutical Biology, 52, 1223-1228. https://doi.org/10.3109/13880209.2014.884606
|
[16]
|
Rufus, P., Mohamed, N. and Shuid, A.N. (2013) Beneficial Effects of Traditional Chinese Medicine on the Treatment of Osteoporosis on Ovariectomised Rat Models. Current drug Targets, 14, 1689-1693.
https://doi.org/10.2174/1389450114666131220160357
|
[17]
|
杨璐尧, 刘翠莲. 中药淫羊藿苷抗骨质疏松的研究进展[J]. 产业与科技论坛, 2021, 20(1): 63.
|
[18]
|
Liu, R., Kang, X., Xu, L., et al. (2015) Effect of the Combined Extracts of Herba Epimedii and Fructus Ligustri Lucidi on Sex Hormone Functional Levels in Osteoporosis Rats. Evidence-Based Complementary and Alternative Medicine: eCAM, 2015, Article ID: 184802. https://doi.org/10.1155/2015/184802
|
[19]
|
Wang, L., Li, Y., Guo, Y., et al. (2016) Herba Epimedii: An Ancient Chinese Herbal Medicine in the Prevention and Treatment of Osteoporosis. Current Pharmaceutical Design, 22, 328-349.
https://doi.org/10.2174/1381612822666151112145907
|
[20]
|
Wang, Z.Q., Li, J.L., Sun, Y.L., et al. (2013) Chinese Herbal Medicine for Osteoporosis: A Systematic Review of Randomized Controlled Trails. Evidence-Based Complementary and Alternative Medicine: eCAM, 2013, Article ID: 356260. https://doi.org/10.1155/2013/356260
|
[21]
|
Liu, M., Li, Y. and Yang, S.T. (2017) Effects of Naringin on the Proliferation and Osteogenic Differentiation of Human Amniotic Fluid-Derived Stem Cells. Journal of Tissue Engineering and Regenerative Medicine, 11, 276-284.
https://doi.org/10.1002/term.1911
|
[22]
|
高文鑫, 陈云刚, 姚康, 等. 骨碎补治疗骨质疏松症的实验研究进展[J]. 中国骨质疏松杂志, 2022, 28(11): 1683-1689.
|
[23]
|
邓强, 乔小万, 李中锋, 等. 骨碎补活性成分治疗骨骼系统疾病研究进展[J]. 辽宁中医药大学学报, 2022, 24(7): 1-5.
|
[24]
|
Ramchandani, D., Ganeshpurkar, A., Bansal, D., et al. (2014) Protective Effect of Curculigo Orchioides Extract on Cyclophosphamide-Induced Neurotoxicity in Murine Model. Toxicology International, 21, 232-235.
https://doi.org/10.4103/0971-6580.155323
|
[25]
|
Vickers, N.J. (2017) Animal Communication: When I’m Calling You, Will You Answer Too? Current Biology: CB, 27, R713-R715. https://doi.org/10.1016/j.cub.2017.05.064
|
[26]
|
Hejazi, I.I., Khanam, R., Mehdi, S.H., et al. (2018) Antioxidative and Anti-Proliferative Potential of Curculigo orchioides Gaertn in Oxidative Stress Induced Cytotoxicity: In Vitro, ex Vivo and in Silico Studies. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 115, 244-259. https://doi.org/10.1016/j.fct.2018.03.013
|
[27]
|
郭鱼波, 马如风, 王丽丽, 等. 女贞子治疗骨质疏松作用及其机制的研究进展[J]. 中草药, 2016, 47(5): 851-856.
|
[28]
|
陈儒骜, 郭雨霏, 董慧静, 等. 女贞子防治骨质疏松作用的中医理论探讨[J]. 中国中医基础医学杂志, 2022, 28(2): 201-204+209.
|
[29]
|
韦秋, 侯佳华, 覃小燕, 等. 女贞子多糖抗去势小鼠骨质疏松作用研究[J]. 天津中医药, 2022, 39(1): 104-109.
|
[30]
|
Zhang, R., Liu, Z.G., Li, C., et al. (2009) Du-Zhong (Eucommia ulmoides Oliv.) Cortex Extract Prevent OVX-Induced Osteoporosis in Rats. Bone, 45, 553-559. https://doi.org/10.1016/j.bone.2008.08.127
|
[31]
|
He, X., Wang, J., Li, M., et al. (2014) Eucommia ulmoides Oliv.: Ethnopharmacology, Phytochemistry and Pharmacology of an Important Traditional Chinese Medicine. Journal of Ethnopharmacology, 151, 78-92.
https://doi.org/10.1016/j.jep.2013.11.023
|
[32]
|
Li, Y., Li, L., Li, X., et al. (2022) A Mechanistic Review of Chinese Medicine Polyphenols on Bone Formation and Resorption. Frontiers in Pharmacology, 13, Article ID: 1017538. https://doi.org/10.3389/fphar.2022.1017538
|
[33]
|
郑洁, 郭海英, 潘思京, 等. 针灸治疗原发性骨质疏松症临床研究进展[J]. 河北中医, 2014, 36(8): 1254-1257.
|
[34]
|
岑卓灏, 陈洁娜, 黄嘉华, 等. 针灸联合多种方法治疗骨质疏松的网状Meta分析[J]. 中国组织工程研究, 2020, 24(2): 320-328.
|
[35]
|
康轶鑫, 王道全, 刘忠厚. 推拿治疗骨质疏松症的研究进展[J]. 中国骨质疏松杂志, 2010, 16(4): 300-307.
|